Evidence map›Paper›PMID 18971267›Full record

ArticleJournal of virology2009

Ubiquitin-independent degradation of hepatitis C virus F protein.

Kamile Yuksek, Wen-Ling Chen, David Chien, Jing-Hsiung James Ou

Abstract read
In one paragraph

Article in Journal of virology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Native structure of rat liver immune proteasomes.Doklady. Biochemistry and biophysics · 2016
    Article
  6. Article
  7. Chaperones in hepatitis C virus infection.World journal of hepatology · 2016
    Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Identification of immunogenic regions within the alternative reading frame protein of hepatitis C virus (genotype 3).European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2011
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Kamile YuksekDepartment of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, USA.
Wen-Ling Chen
David Chien
Jing-Hsiung James Ou
University of Southern California · USNovartis (United States) · US

Funding

Molecular analysis of the HCV F geneR01AI060559 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI OU, J.-H. JAMES · 2003 to 2007
$1.4M
VIROLOGY, IMMUNOLOGY &ONCOLOGY: MECHANISMS OF DISEASET32AI007078 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LAI, MICHAEL M.C. · 1985 to 2006
$1.1M
NIAID NIH HHS R01 AI060559NIAID NIH HHS R01AI060559NIAID NIH HHS T32 AI007078NIAID NIH HHS T32AI007078
6 · The paper itself

Abstract

Hepatitis C virus (HCV) F protein is encoded by the +1 reading frame of the viral genome. It overlaps with the core protein coding sequence, and multiple mechanisms for its expression have been proposed. The full-length F protein that is synthesized by translational ribosomal frameshift at codons 9 to 11 of the core protein sequence is a labile protein. By using a combination of genetic, biochemical, and cell biological approaches, we demonstrate that this HCV F protein can bind to the proteasome subunit protein alpha3, which reduces the F-protein level in cells in a dose-dependent manner. Deletion-mapping analysis identified amino acids 40 to 60 of the F protein as the alpha3-binding domain. This alpha3-binding domain of the F protein together with its upstream sequence could significantly destabilize the green fluorescent protein, an otherwise stable protein. Further analyses using an F-protein mutant lacking lysine and a cell line that contained a temperature-sensitive E1 ubiquitin-activating enzyme indicated that the degradation of the F protein was ubiquitin independent. Based on these observations as well as the observation that the F protein could be degraded directly by the 20S proteasome in vitro, we propose that the full-length HCV F protein as well as the F protein initiating from codon 26 is degraded by an ubiquitin-independent pathway that is mediated by the proteasome subunit alpha3. The ability of the F protein to bind to alpha3 raises the possibility that the HCV F protein may regulate protein degradation in cells.

Indexed as

AnimalsArtificial Gene FusionCell LineGenes, ReporterGreen Fluorescent ProteinsHumansMiceProteasome Endopeptidase ComplexProtein BindingProtein Interaction Domains and MotifsProtein Interaction MappingRecombinant Fusion ProteinsSequence DeletionTwo-Hybrid System TechniquesUbiquitinViral Core ProteinsGreen Fluorescent Proteinshepatitis C protein F, Hepatitis C virusProteasome Endopeptidase ComplexPSMA3 protein, humanRecombinant Fusion ProteinsUbiquitinViral Core Proteins

Identifiers

PMID18971267
PMCPMC2612388
OpenAlexW2022250634

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.